Cook Medical Inc. Sustainability Profile
Cook Medical Inc., a prominent player in the medical device industry, is headquartered in the United States and operates extensively across Europe, Asia, and other global regions. Founded in 1963, the company has established itself as a leader in innovative medical solutions, particularly in the fields of vascular intervention, urology, and gastroenterology. With a diverse portfolio of products, including catheters, stents, and surgical instruments, Cook Medical is renowned for its commitment to quality and patient care. The company’s unique approach to product development, which emphasises collaboration with healthcare professionals, sets it apart in a competitive market. Cook Medical's dedication to advancing medical technology has earned it a strong market position, marked by numerous accolades and a reputation for reliability and innovation in patient treatment solutions.
DitchCarbon Score
How does Cook Medical Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cook Medical Inc.'s score of 39 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cook Medical Inc.'s reported carbon emissions
In 2024, Cook Medical Inc. reported total carbon emissions of approximately 96,000 kg CO2e, comprising 4,000 kg CO2e from Scope 1, 12,000 kg CO2e from Scope 2, and 84,000 kg CO2e from Scope 3 emissions. This marks a significant reduction from previous years, where in 2023, the company emitted about 3,719,356 kg CO2e, with Scope 1 and Scope 2 emissions each at approximately 1,859,678 kg CO2e. In 2022, emissions were notably higher, with Scope 1 at about 20,975,800 kg CO2e and Scope 2 at approximately 2,095,890 kg CO2e. The 2021 figures were even more substantial, with Scope 1 emissions reaching about 24,330,000 kg CO2e and Scope 2 at approximately 75,670,000 kg CO2e. Despite these reductions, Cook Medical has not set specific science-based targets (SBTi) or documented reduction initiatives. The company operates as a current subsidiary of Cook Medical Inc., and all emissions data is sourced directly from their reporting. The absence of Scope 3 emissions data in 2023 and prior years indicates a potential area for future focus in their climate commitments. Overall, Cook Medical's emissions trajectory reflects a commitment to reducing their carbon footprint, although further transparency regarding specific reduction targets would enhance their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 24,330,000 | 00,000,000 | 0,000,000 | 0,000 |
| Scope 2 | 75,670,000 | 0,000,000 | 0,000,000 | 00,000 |
| Scope 3 | - | - | - | 00,000 |
How Carbon Intensive is Cook Medical Inc.'s Industry?
How Carbon Intensive is Cook Medical Inc.'s Location?
Cook Medical Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cook Medical Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
